| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.12 | 8e-05 |